Keywords: Epilepsy drug market, Generic erosion, Decision Resources

Epilepsy drug market to remain relatively flat through 2019 as generic erosion is offset by the launch of new therapies, says DR report

Article | 25 October 2010

Over the next decade, the epilepsy drug market will remain relatively flat, increasing from $2.8 billion in 2009 to $2.9 billion in 2019 in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in